BioSpace News Archive

Rising prevalence of neglected tropical diseases (NTDs) worldwide coupled with growing demand for advanced rabies diagnostic solutions to boost market growth.

Growing global incidence of substance abuse, increasing cases of prescription diversion, and stringent laws mandating drug screening tests are key factors driving market growth.

Rising prevalence of Zika virus, increasing public awareness, and growing footprint of local manufacturers of rapid tests for Zika virus are key factors boosting global market growth.

Repertoire Immune Medicines announced today that Science Advances published preclinical research demonstrating the company’s cell-tethering technology can deliver the potent cytokine interleukin-12 (IL-12) to solid tumors without eliciting the severe systemic toxicities typically associated with the use of this cytokine.

Today, Nocira is pleased to announce its device, which uses gentle, controlled puffs of air in the ears (called “Automated Variable Pulse Insufflation™" or “AVPI”), was officially designated by the FDA as a “Breakthrough Device” for the acute treatment of migraine by patients 18 years or older.

The global Scar Treatment market size is expected to hit over US$ 56.3 billion by 2030 and is projected to grow at a CAGR of 15.1% during forecast period 2021 to 2030.

The global Neurovascular Catheters market size is expected to surpass around US$ 14.83 billion by 2030 from valued at US$ 5.88 billion in 2020 and to grow at a CAGR of 10.7% from 2021 to 2030.

Aruna Bio, a leader in the development of neural exosomes for the treatment of neuro-inflammatory and neurodegenerative diseases, announced the appointment of Stephen From as Chief Executive Officer.

The U.S. Food and Drug Administration issued draft action levels for lead in single-strength apple juice and other single-strength juices and juice blends.

ResMed announced Brett Sandercock, chief financial officer, will present virtually at the Macquarie Australia Conference on Tuesday, May 3, 2022, beginning at approximately 8:45 a.m. via video webcast.